BenevolentAI acquires facility at Babraham campus

BenevolentAI (London, U.K.) acquired a drug discovery and development facility on the Babraham Research Campus (Cambridge, U.K.) for an undisclosed amount.

The AI company will integrate with a team from the Cambridge campus to use AI to advance "the right drugs to the right patients."...